Genetically modified plants potentially fighting the disease that's kills more people every year than war... pretty amazing stuff.
Gene silencing can stop the opium poppy producing morphine and instead force it to produce large amounts of a compound useful in the fight against malaria.
The poppy Papaver somniferum accumulates morphine, codeine and other opiates in its latex - its sap-like substance. The synthesis of these opiates in the plant involves a long and complex series of steps.
A team led by Philip Larkin from CSIRO Plant Industry in Canberra, Australia, used RNA interference (RNAi) to silence - or “turn off” - the genes responsible for producing an enzyme called codeinone reductase. This in turn stopped the synthesis of the opiates at the stage at which a compound called reticuline is produced.
"Instead of morphine and the other opiates, large amounts of reticuline are accumulated in the latex," says Larkin.
Ethnobotanical studies of traditional herbal remedies for malaria from around the world have found that the active ingredient is very often an alkaloid comprised of two reticuline molecules. There is an urgent need for new anti-malarial drugs, and poppies modified by RNAi silencing or mutation could be an ideal source of reticuline, says Larkin.